Biotech Firm Coming To Pearland

Lonza Group, a massive Swiss pharmaceutical company, plans to build a 100k SF biotech facility in Pearland that will replace Lonza’s existing Houston operations. The new facility will be on an 11-acre plot in Pearland’s Lower Kirby District.

The Pearland Economic Development Council and Lonza have been in discussions since 2014, according to the Houston Business Journal. Fort Worth-based Rogue Architects is the architect of record.

The new facility will have 100k SF of office space, labs and other areas that will facilitate the production of its viral gene and virally modified therapeutics. [HBJ]

Continue reading this story with a free account

Log in or register
Sign up for more articles like this
Subscribe to Bisnow's Houston Newsletters
Related Stories

Texas Flips Blue, Putting Data Center Boom On Notice

Big Money Bets On SoCal Industrial As 2 Portfolio Sales Top $3B

2.7M SF Campus Trades In Houston's Largest Industrial Sale

Piedmont Realty Exiting Houston Market With Office Dispositions

Nord Group's Lawyer Moves To Quit, Says Entities Can't Pay Him

Gaming & Leisure Stays Bullish On Bally's Casino Project Despite Delays

Brookfield, CPP Complete $5.2B REIT Buyout, Pick Up U.S. Logistics Assets

Taiwan Semiconductor Manufacturing Co. Could Expand In North Texas

Credit Union Breaks Ground On New HQ Building: The Houston Deal Sheet

EXCLUSIVE: Downtown Houston+ Targets Grocery Gap, Pedestrian Experience With New Programs

Prologis To Develop 3.8M SF Industrial Park On Former Casino Site

Foundry Robotics Leaves San Francisco For New East Bay HQ